Fueled by the expertise of a team of international specialist
authors, this first reference on the booming topic covers
everything a drug researcher needs to know about targeting
epigenetic mechanisms of disease.
The first part of the book surveys current methodologies for
finding and validating drug candidates that act via epigenetic
mechanisms. The second part systematically surveys known and
suspected drug targets within the epigenetic machinery, including
the discovery and development of vorinostat, the first marketed
epigenetic drug.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!